Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,078 | -4,794 | -2,389 | -6,939 | -3,993 |
| Depreciation Amortization | 42 | 5 | 3 | 26 | 24 |
| Accounts payable and accrued liabilities | -232 | 128 | -45 | 532 | 382 |
| Other Working Capital | -982 | -991 | -1,459 | 1,342 | 428 |
| Other Operating Activity | 723 | 202 | 203 | -249 | -257 |
| Operating Cash Flow | $-7,527 | $-5,450 | $-3,687 | $-5,288 | $-3,416 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -5 | N/A | -32 | -28 |
| Investing Cash Flow | $-5 | $-5 | $N/A | $-32 | $-28 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,038 | 9,038 | 9,018 | 1,741 | 1,741 |
| Other Financing Activity | -1,013 | -962 | -885 | 17,415 | 17,415 |
| Financing Cash Flow | $8,025 | $8,076 | $8,133 | $19,156 | $19,156 |
| Beginning Cash Position | 16,756 | 16,756 | 16,756 | 2,920 | 2,920 |
| End Cash Position | 17,249 | 19,377 | 21,202 | 16,756 | 18,632 |
| Net Cash Flow | $493 | $2,621 | $4,446 | $13,836 | $15,712 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,527 | -5,450 | -3,687 | -5,288 | -3,416 |
| Capital Expenditure | -5 | -5 | N/A | -32 | -28 |
| Free Cash Flow | -7,532 | -5,455 | -3,687 | -5,320 | -3,444 |